Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues

被引：38

作者：

Fan, GK

Chen, J

Ping, FY

Geng, YH

机构：

[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Oral & Maxillofacial Surg, Hangzhou 310009, Zhejiang, Peoples R China

[2] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Otorhinolaryngol, Hangzhou 310009, Zhejiang, Peoples R China

[3] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Pathol, Hangzhou 310009, Zhejiang, Peoples R China

来源：

ORAL ONCOLOGY | 2006年 / 42卷 / 02期

关键词：

oral leukoplakia; cancer; p57(kip2); p53; hsp60;

D O I：

10.1016/j.oraloncology.2005.06.017

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

To investigate the expressions and significances of P57(kip2), p53 and hsp60 proteins in the dysplasia-carcinoma sequence of oral mucosa. A retrospective study was performed in 10 cases of normal oral mucosa, 79 cases of leukoplakia and 67 cases of squamous cell carcinoma (SCC). The expressions of P57(kip2), p53 and hsp60 proteins were detected in the tissue samples of these populations using immunohistochemical method. P57(kip2) expression was decreased in oral leukoplakia with moderate or severe dysplasia, and further decreased in oral SCC. Negative expression of P57(kip2) was significantly associated with advanced tumor size, the occurrence of Lymph node metastasis and the advanced clinical stage in oral SCC. The overall 5-year survival rate in the P57(kip2) positive group was significantly higher than that in the P57(kip2) negative group. P57(kip2) expression was decreased in oral leukoplakia with moderate or severe dysplasia, and further decreased in oral SCC. It was a remarkable progressive and prognostic biomarker in oral SCC. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：147 / 153

页数：7

共 25 条

[1]

Cappello F, 2003, EUR J HISTOCHEM, V47, P105

[2]

Chaiyarit P, 1999, J ORAL PATHOL MED, V28, P210

[3] Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland [J].

Cruz, I ;

Napier, SS ;

van der Waal, I ;

Snijders, PJF ;

Walboomers, JMM ;

Lamey, PJ ;

Cowan, CG ;

Gregg, TA ;

Maxwell, P ;

Meijer, CJLM .

JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (02) :98-104

[4]

Feinberg AP, 1999, CANCER RES, V59, p1743S

[5]

GRANA X, 1995, ONCOGENE, V11, P211

[6]

Kondo M, 1996, ONCOGENE, V12, P1365

[7] Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia [J].

Kurokawa, H ;

Matsumoto, S ;

Murata, T ;

Yamashita, Y ;

Tomoyose, T ;

Zhang, M ;

Fukuyama, H ;

Takahashi, T .

JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2003, 32 (09) :513-521

[8]

Lai SL, 2000, CLIN CANCER RES, V6, P3172

[9]

Lee JJ, 2000, CLIN CANCER RES, V6, P1702

[10] CLONING OR P57(KIP2), A CYCLIN-DEPENDENT KINASE INHIBITOR WITH UNIQUE DOMAIN-STRUCTURE AND TISSUE DISTRIBUTION [J].

LEE, MH ;

REYNISDOTTIR, I ;

MASSAGUE, J .

GENES & DEVELOPMENT, 1995, 9 (06) :639-649

← 1 2 3 →